Clinical Trial Update: Evaluation of Sphingolipids as Predictive Biomarkers of Immune Checkpoint Inhibitor Response in Melanoma Patients [NA]

View source ↗

Summary

This clinical trial update reports the completion of a study evaluating sphingolipids as predictive biomarkers for response to immune checkpoint inhibitors in m…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Institut Claudius Regaud | Conditions: Melanoma | NA | Status: COMPLETED